3Ekpe A,Jacobsen B.Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography[J ]. Drug Dev Ind Pharm, 1999,25(9): 1 057.
5Chikawa T,Ishihara,Saigenjik.Effect of acid-inhibitory antiulcer druys on mucin biosynthesis in the rat stomach[].European Journal of Haematology.1994
6Barkun A,Bardou M,Marshall JK.Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding[].Annals of Internal Medicine.2003
7Metz DC.Potential uses of intravenous proton pump inhibitors to control gastric acid secretion[].Digestion.2000
8Shin JM,Besan con M,Simon A,et al.The site of action of pantoprazole in the gastric H+-K+-ATPase[].Biochimica et Biophysica Acta.1993
9Mctavish D,Buckley M,Hell KC.Omeprazole: An update review of itspharmacology and therapeutic use in acid- related disorders[].Drugs.1991
10Patchett SE,O’Donoghue DP.Pharmacological manipulation of gastric juice: thrombelastographic assessment and implication for treatment of gastrointetsinal haemorrhage[].Gut.1995
8Ll X Q, Andersson T B, Ahlstrom M,et al. Comparison of Inhibitory effects of the proton pump-inhibiting drugs omeprazole,esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human eytoehrome P450 activities[J]. Drug Metabolism and Disposition, 2004,32(8) :821-827.
9Langankel M, Brothers K B, Erdmannl P, et al. Comparing different scientific approaches to personalized medicine: research ethics and privacy protection[J]. Per Med, 2011,8 (4) : 437-444.
10Barbara G S, Urszula A G, Elzbieta W, et al. CYP2C 19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers[]]. Eur J Clin Pharmaeol,2012,68 : 1267-1274.
